Skip to search formSkip to main contentSkip to account menu

montirelin

Known as: methyl(6)-oxothiomorpholinyl(5)-carbonyl-His(3)-ProNH2, 6-methyl-5-oxothiomorpholinyl-3-carbonylhistidyl prolinamide, Me(6)-oxothiomorpholinyl(5)-carbonylhistidyl(3)-prolinamide 
National Institutes of Health

Related topics

Related topics

9 relations

Narrower (7)

CG 3703CNK 602ACNK 603NS-3

Broader (1)

Thyrotropin-Releasing Hormone
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Studies on the transport of thyrotropin‐releasing hormone (TRH) analogues in Caco‐2 cell monolayers
The transport mechanisms of thyrotropin‐releasing hormone (TRH) and its pharmacologically active analogues ((3‐methyl‐His2)TRH… 
2001
2001
Brain receptor binding characteristics and pharmacokinetic-pharmacodynamic analysis of thyrotropin-releasing hormone analogues.
Review
2001
Review
2001
Neurosurgical Trauma in Japan
According to the statistics compiled by the Institute for Traffic Accident Research and Data Analysis, the total number of head… 
1996
1996
Montirelin to inhibit sleep apnea.
It DESCRIBES A PROCEDURE FOR TREATED Obstructive Sleep Apnea BY administering an amount effective to inhibit SLEEP APNEA 6… 
1996
1996
Montirelin hydrate(NS‐3)の意識障害患者に対する臨床後期第II相試験 至適用量の検討
1996
1996
Montirelin for prevention of sleep apnea
1995
1995
Permeability of NS‐3, a Thyrotropin‐releasing Hormone Analogue, into the Brain After Its Systemic Administration in Rats: A Microdialysis Study
The concentration of NS‐3 (montirelin hydrate, CG 3703), a thyrotropin‐releasing hormone (TRH) analogue, in the cerebral cortex… 
1995
1995
MONTIRELIN HYDRATE (NS-3)のラットにおける5週間反復静脈内投与毒性試験ならびに4週間回復試験
1995
1995
Montirelin hydrate (NS-3)の一般薬理作用
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)